The Department of Urology and the Institute for Prostate and Urologic Cancers are pleased to share the latest U.S. News & World Report Best Hospitals rankings. M Health Fairview University of Minnesota Medical Center (UMMC) has once again been recognized as the #1 hospital in the Twin Cities metro area and #2 in Minnesota, rising from #3 in the state rankings last year. M Health Fairview Southdale Hospital was also recognized among the region's best, ranking #2 in the Twin Cities and #3 in Minnesota.

Beyond these rankings, UMMC earned national recognition for excellence across multiple specialty areas and was named a Best Regional Hospital for Community Access, highlighting its success in providing high-quality care to patients from all socioeconomic backgrounds throughout Minnesota and the Upper Midwest.

The Department of Urology is especially proud of UMMC's recognition for high performance in prostate cancer surgery, with outcomes rated significantly better than the national average. This distinction reflects exceptional performance in key measures including patient outcomes, survival rates, patient experience, and overall quality of care.

These achievements underscore the strength of the University of Minnesota's integrated approach to urologic cancer care, bringing together nationally recognized surgeons, medical and radiation oncologists, radiologists, scientists, and specialized care teams to deliver innovative, evidence-based treatment. As a recognized Center of Excellence in prostate cancer imaging and home to the Masonic Cancer Center, one of only two National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in Minnesota, the University of Minnesota is uniquely positioned to translate groundbreaking research into advanced therapies for patients with prostate and other urologic cancers.

From leading-edge imaging and precision diagnostics to robotic surgery, clinical trials, and multidisciplinary cancer care, our teams continue to advance the field while improving outcomes for patients across Minnesota and beyond.

Thank you to our faculty, providers, researchers, and staff whose dedication and expertise make these accomplishments possible. Together, we remain committed to delivering exceptional care and shaping the future of urology and cancer treatment.